<--- Back to Details
First PageDocument Content
Amyotrophic lateral sclerosis / Riluzole / Anatomy / Pseudobulbar palsy / Pseudobulbar affect / Current Procedural Terminology / ALS Society of Canada / ALS Association / Motor neurone disease / Rare diseases / Health
Date: 2012-02-15 15:52:49
Amyotrophic lateral sclerosis
Riluzole
Anatomy
Pseudobulbar palsy
Pseudobulbar affect
Current Procedural Terminology
ALS Society of Canada
ALS Association
Motor neurone disease
Rare diseases
Health

Executive Summary: Towards Improving Outcomes for Patients with ALS

Add to Reading List

Source URL: patients.aan.com

Download Document from Source Website

File Size: 979,77 KB

Share Document on Facebook

Similar Documents

Clinical trials / ClinicalTrials.gov / Multiple sclerosis / Tecemotide / Pseudobulbar affect

CLINICAL TRIALS FUNDED BY THE NATIONAL MS SOCIETY Updated January 2016 Abbreviations Key: AAN – American Academy of Neurology ECTRIMS – European Committee for Treatment and Research in Multiple Sclerosis

DocID: 1osEZ - View Document

Dextromethorphan Plus Ultra LowDose Quinidine Reduces Pseudobulbar Affect

DocID: 1eyXe - View Document

Emergency medicine / Traumatic brain injury / Stress / Pseudobulbar affect / Major depressive disorder / Posttraumatic stress disorder / Acquired brain injury / Anxiety / Antidepressant / Medicine / Neurotrauma / Psychiatry

Emotional Problems After Traumatic Brain Injury Traumatic Brain Injury Model System Consumer Information Brain injury and emotions For more information,

DocID: 19BAf - View Document

Rare diseases / Amyotrophic lateral sclerosis / Riluzole / Current Procedural Terminology / Pseudobulbar palsy / Pseudobulbar affect / Patient safety / ALS Association / ALS Society of Canada / Health / Medicine / Motor neurone disease

Executive Summary: Towards Improving Outcomes for Patients with ALS

DocID: 14ZbG - View Document

Pseudobulbar affect / Dextromethorphan / Pseudobulbar palsy / Forward-looking statement / Government procurement in the United States / Neurochemistry / Pharmacology / Biochemistry

ソフトチーム検討事項

DocID: Wr3U - View Document